CA19-9/GGT比值、ALT/AST比值联合NLR对可切除结直肠癌肝转移患者预后的预测价值

罗辉 ,  李清 ,  王永辉 ,  耿兴隆

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (7) : 582 -586.

PDF (386KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (7) : 582 -586. DOI: 10.12007/j.issn.0258‐4646.2026.07.002
论著

CA19-9/GGT比值、ALT/AST比值联合NLR对可切除结直肠癌肝转移患者预后的预测价值

作者信息 +

Predictive value of the CA19-9/GGT ratio and the ALT/AST ratio combined with the NLR for the prognosis of patients with resectable colorectal cancer liver metastasis

Author information +
文章历史 +
PDF (394K)

摘要

目的 探讨糖类抗原19-9 (CA19-9) /γ-谷氨酰转肽酶 (GGT) 比值、丙氨酸氨基转移酶 (ALT) /天冬氨酸氨基转移酶 (AST) 比值 (LSR)、中性粒细胞/淋巴细胞计数比值 (NLR) 联合对可切除结直肠癌肝转移 (CRLM) 患者预后的预测价值。方法 选取2021年1月至2025年1月间于我院行肝切除术的100例CRLM患者,术后进行为期1年的随访,根据是否复发分为预后良好组与预后不良组。通过Cox回归分析CRLM患者预后的影响因素,采用受试者操作特征 (ROC) 曲线评估CA19-9/GGT比值、LSR、NLR对CRLM患者预后的预测价值。结果 43% (43/100) 的CRLM患者术后1年内复发,57% (57/100) 未复发。2组肝转移范围分布差异有统计学意义 (χ2=5.262,P < 0.05)。与预后良好组比较,预后不良组CA19-9/GGT比值、NLR水平升高,而LSR水平降低 (P均<0.05)。Cox回归分析结果显示,CA19-9/GGT比值 (HR = 2.518,95%CI:1.159~5.472)、NLR (HR = 2.073,95%CI:1.170~3.674) 是CRLM患者预后危险因素,LSR是CRLM患者预后保护因素 (HR = 0.739,95%CI:0.561~0.974)。ROC曲线分析结果显示,CA19-9/GGT比值、LSR、NLR对CRLM患者预后预测的曲线下面积 (95%CI) 分别为0.853 (0.769~0.936)、0.810 (0.720~0.900)、0.795 (0.703~0.887),三者联合对CRLM患者预后预测的曲线下面积 (95%CI) 为0.949 (0.904~0.993),三者联合对CRLM患者预后预测价值优于单独预测 (Z联合-CA19-9/GGT比值=2.537、P = 0.011,Z联合-LSR=3.111、P = 0.002,Z联合-NLR=3.548、P < 0.001)。结论 CA19-9/GGT比值、LSR、NLR与CRLM患者术后预后有关,三者联合对CRLM患者预后有潜在预测价值。

Abstract

Objective To determine the predictive value of the combined use of the carbohydrate antigen 19-9 (CA19-9) to gamma-glu tamyl transpeptidase (GGT) ratio,the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) ratio,the lipolysis-stimulated lipoprotein receptor (LSR) level,and the neutrophil-to-lymphocyte ratio (NLR),for the prognosis of patients with resectable colorectal cancer liver metastasis (CRLM). Methods A total of 100 patients with CRLM who underwent hepatectomy in our hospital between Jan uary 2021 and January 2025 were included. They were followed up for one year post-surgery,and assigned to a good prognosis group (no recurrence) or a poor prognosis group (recurrence). Cox regression analysis was used to identify the prognostic factors for patients with CRLM,and the predictive value of the CA19-9/GGT ratio,the LSR level,and the NLR for the prognosis of patients with CRLM was eva- luated using receiver operating characteristic curve (ROC) analysis. Results Forty-three of the 100 patients with CRLM had recurrence within one year post-surgery. There was a statistically significant difference in the distribution of the range of liver metastasis between the two groups (χ2 = 5.262,P < 0.05). The poor prognosis group,had a higher mean CA19-9/GGT ratio,a higher mean NLR,and a lower mean LSR level than the good prognosis group (all P < 0.05). Cox regression analysis showed that the CA19-9/GGT ratio (HR = 2.518,95%CI:1.159-5.472) and NLR (HR = 2.073,95%CI:1.170-3.674) were risk factors for the prognosis of patients with CRLM,and the LSR level was a protective factor (HR = 0.739,95%CI:0.561-0.974). ROC curve analysis showed that the area under the curve (95%CI) for the prediction of prognosis by the CA19-9/GGT ratio,the LSR level,and the NLR were 0.853 (0.769-0.936),0.810 (0.720-0.900),and 0.795 (0.703-0.887),respectively. The area under the curve (95%CI) for the combined prediction of the three factors was 0.949 (0.904-0.993),and the combined prediction value was superior to that of individual prediction (Zcombination-CA19-9/GGT ratio = 2.537,P = 0.011,Zcombination-LSR = 3.111,and P = 0.002,Zcombination-NLR = 3.548,P < 0.001). Conclusion The CA19-9/GGT ratio,the LSR level,and the NLR are related to the prognosis of patients with CRLM post-surgery,and the combined use of these three factors has potential predictive value for the prognosis of patients with CRLM.

关键词

结直肠癌肝转移 / 预后 / 糖类抗原19-9/γ-谷氨酰转肽酶比值 / 丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值 / 中性粒细胞/淋巴细胞计数比值

Key words

colorectal cancer liver metastasis / prognosis / carbohydrate antigen 19-9/γ-glutamyl transpeptidase ratio / alanine ami notransferase/aspartate aminotransferase ratio / neutrophil-to-lymphocyte ratio

引用本文

引用格式 ▾
罗辉,李清,王永辉,耿兴隆. CA19-9/GGT比值、ALT/AST比值联合NLR对可切除结直肠癌肝转移患者预后的预测价值[J]. 中国医科大学学报, 2026, 55(7): 582-586 DOI:10.12007/j.issn.0258‐4646.2026.07.002

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

BAIDOUN F,ELSHIWY K,ELKERAIE Y,et al. Colorectal cancer epidemiology:recent trends and impact on outcomes [J]. Curr Drug Targets,2021,22 (9):998-1009. DOI:10.2174/1389450121999201117115717.

[2]

LI N,LU B,LUO CY,et al. Incidence,mortality,survival,risk fac tor and screening of colorectal cancer:a comparison among China, Europe,and northern America [J]. Cancer Lett,2021,522:255-268. DOI:10.1016/j.canlet.2021.09.034.

[3]

LI R,LIU XF,HUANG XD,et al. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis [J]. Gut,2024,73 (3):470-484. DOI:10.1136/gutjnl-2023-330243.

[4]

BERTOCCHI A,CARLONI S,RAVENDA PS,et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver [J]. Cancer Cell,2021,39 (5):708-724.e11. DOI:10.1016/j.ccell.2021.03.004.

[5]

GIANNIS D,SIDERIS G,KAKOS CD,et al. The role of liver trans plantation for colorectal liver metastases:a systematic review and pooled analysis [J]. Transplant Rev,2020,34 (4):100570. DOI:10.1016/j.trre.2020.100570.

[6]

NASSABEIN R,MANSOUR L,RICHARD C,et al. Outcomes of older patients with resectable colorectal liver metastases cancer (CRLM): single center experience [J]. Curr Oncol,2021,28 (3):1899-1908. DOI:10.3390/curroncol28030176.

[7]

LIANG JY,LIN HC,LIU JW,et al. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepa tectomy [J]. Cancer Med,2021,10 (5):1535-1544. DOI:10.1002/cam4.3697

[8]

PIETERS A,GIJBELS E,COGLIATI B,et al. Biomarkers of cholesta sis [J]. Biomark Med,2021,15 (6):437-454. DOI:10.2217/bmm-2020-0691.

[9]

CHEN RQ,ZHANG ZL,JIA YM,et al. Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma [J]. BMC Gastroenterol,2023,23 (1):72. DOI:10.1186/s12876-022-02623-0.

[10]

TAMBER SS,BANSAL P,SHARMA S,et al. Biomarkers of liver diseases [J]. Mol Biol Rep,2023,50 (9):7815-7823. DOI:10.1007/s11033-023-08666-0.

[11]

TAN SF,ZHENG Q,ZHANG W,et al. Prognostic value of inflamma tory markers NLR,PLR,and LMR in gastric cancer patients treated with immune checkpoint inhibitors:a meta-analysis and systematic review [J]. Front Immunol,2024,15:1408700. DOI:10.3389/fimmu.2024.1408700

[12]

NISHIOKA Y,CHUN YS,OVERMAN MJ,et al. Effect of co-mu tation of RAS and TP53 on postoperative ctDNA detection and early recurrence after hepatectomy for colorectal liver metasta ses [J]. J Am Coll Surg,2022,234 (4):474-483. DOI:10.1097/xcs.0000000000000093.

[13]

LYU SC,WANG J,HUANG MX,et al. CA19-9 level to serum γ-glu tamyltransferase as a potential prognostic biomarker in patients with pancreatic head carcinoma [J]. Cancer Manag Res,2021,13:4887-4898. DOI:10.2147/cmar.s313517.

[14]

陈红旭,庄宏宇,胡博,等. 血清铁、CA19-9/GGT比值与肝细胞癌微血管侵犯、术后复发和预后的关系 [J]. 中西医结合肝病杂志, 2024,34 (7):600-604. DOI:10.3969/j.issn.1005-0264.2024.007.006.

[15]

王芳菲,吕少诚,曹迪,等. 术前CA19-9/GGT比值与远端胆管癌术后远期生存的相关性分析 [J]. 中华肝胆外科杂志,2021,27 (10):762-766. DOI:10.3760/cma.j.cn113884-20201215-00624.

[16]

LI GP,ZHANG D,LI MH,et al. Association between the neutro phil-to-lymphocyte ratio and cancer in adults from NHANES 2005- 2018:a cross-sectional study [J]. Sci Rep,2024,14:23678. DOI:10.1038/s41598-024-75252-0.

[17]

CHEN WC,XIN S,XU BH. Value research of NLR,PLR,and RDW in prognostic assessment of patients with colorectal cancer [J]. J Healthc Eng,2022,2022:7971415. DOI:10.1155/2022/7971415.

[18]

李大伟,周振堰,周长友,等. ALT/AST及影像学特征预测肝癌经动脉化疗栓塞患者的预后 [J]. 介入放射学杂志,2024,33 (8):849-854. DOI:10.3969/j.issn.1008-794X.2024.08.007.

[19]

CHEN WY,WANG WB,ZHOU LL,et al. Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident [J]. J Clin Lab Anal,2022,36 (5):e24356. DOI:10.1002/jcla.24356.

基金资助

国家自然科学基金(82303337)

AI Summary AI Mindmap
PDF (386KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉